>
Switch to:

Calliditas Therapeutics AB Days Sales Outstanding

: 0.00 (As of Dec. 2020)
View and export this data going back to 2020. Start your Free Trial

Calliditas Therapeutics AB's average Accounts Receivable for the three months ended in Dec. 2020 was $0.00 Mil. Calliditas Therapeutics AB's Revenue for the three months ended in Dec. 2020 was $0.05 Mil. Hence, Calliditas Therapeutics AB's Days Sales Outstanding for the three months ended in Dec. 2020 was 0.00.

NAS:CALT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 92   Med: 9773.63   Max: 19455.25
Current: 19455.25

92
19455.25

During the past 6 years, Calliditas Therapeutics AB's highest Days Sales Outstanding was 19455.25. The lowest was 92.00. And the median was 9773.63.

NAS:CALT's Days Sales Outstanding is ranked lower than
99.99% of the 996 Companies
in the Drug Manufacturers industry.

( Industry Median: 71.78 vs. NAS:CALT: 19455.25 )

Calliditas Therapeutics AB's Days Sales Outstanding declined from Dec. 2019 (91.25) to Dec. 2020 (0.00).

Warning Sign:

If a company sales outstanding increases, it means it has difficulty collecting payment from its customers.


Calliditas Therapeutics AB Days Sales Outstanding Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Days Sales Outstanding Premium Member Only - - - 92.00 17,249.72

Calliditas Therapeutics AB Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.25 9,359.36 - - -

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calliditas Therapeutics AB Days Sales Outstanding Distribution

* The bar in red indicates where Calliditas Therapeutics AB's Days Sales Outstanding falls into.



Calliditas Therapeutics AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Calliditas Therapeutics AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2020 is calculated as

Days Sales Outstanding (A: Dec. 2020 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2019 ) + Accounts Receivable (A: Dec. 2020 )) / count ) / Revenue (A: Dec. 2020 )*Days in Period
=( (4.9389338874518 + 0) / 1 ) / 0.10450670206024*365
=4.9389338874518 / 0.10450670206024*365
=17,249.72

Calliditas Therapeutics AB's Days Sales Outstanding for the quarter that ended in Dec. 2020 is calculated as:

Days Sales Outstanding (Q: Dec. 2020 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2020 ) + Accounts Receivable (A: Dec. 2020 )) / count ) / Revenue (A: Dec. 2020 )*Days in Period
=( (0 + 0) / 1 ) / 0.04782915426098*365 / 4
=0 / 0.04782915426098*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Calliditas Therapeutics AB  (NAS:CALT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Calliditas Therapeutics AB Days Sales Outstanding Related Terms


Calliditas Therapeutics AB Days Sales Outstanding Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)